Fate Therapeutics Inc (FATE)

EBITDA Margin

-1762.49%

TTM · Period ending:

FATE logo

FATE EBITDA Margin

Latest reported-1762.49%
FATE TTM EBITDA Margin (-826.33% → -1762.49%)
High-resolution chart · PNG

FATE ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Fate Therapeutics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-1,762.4865%
-1,859.1039%
-1,856.9666%
-1,909.78%
-1,775.0767%
-1,149.3288%
-1,189.6266%
-1,183.8849%
-1,271.0563%
-2,641.8493%
-224.5227%
-145.8673%
-163.413%
-160.5395%
-278.2586%
-409.8605%
-357.8768%
-356.6223%
-371.4045%
-317.412%
-338.4228%
-340.6355%
-397.6522%
-652.132%
-866.7701%
-1,032.6233%
-882.0599%
-863.1198%
-894.2232%
-1,090.0725%
-1,343.8397%
-1,466.7073%
-1,321.0424%
-1,083.9464%
-991.549%
-884.7053%
-837.7496%
-802.7027%
-704.2708%
-680.656%
-635.8796%
-735.0919%
-1,114.5619%
-1,934.3911%
-7,884.1945%
2,406.0762%
2,953.0184%
4,638.9831%
-1,083.2714%
-826.3321%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.